tiprankstipranks
Trending News
More News >
Cue Biopharma Inc (CUE)
NASDAQ:CUE
US Market

Cue Biopharma (CUE) Technical Analysis

Compare
606 Followers

Technical Sentiment

Overall Consensus
Neutral
7Bullish
6Neutral
9Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Cue Biopharma Inc’s (CUE) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Cue Biopharma Inc is a Sell.
Cue Biopharma Inc’s (CUE) 20-Day exponential moving average is 0.69, while Cue Biopharma Inc’s (CUE) share price is $0.7, making it a Buy.
Cue Biopharma Inc’s (CUE) 50-Day exponential moving average is 0.72, while Cue Biopharma Inc’s (CUE) share price is $0.7, making it a Sell.

Cue Biopharma (CUE) Pivot Points

Jul 07, 2025, 06:36 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.60
0.62
0.66
0.68
0.72
0.74
0.78
Fibonacci
0.62
0.65
0.66
0.68
0.71
0.72
0.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cue Biopharma (CUE) Moving Averages

Jul 07, 2025, 06:36 PM
Period
Simple
Exponential
MA5
0.70Buy
0.70Buy
MA10
0.71Sell
0.70Buy
MA20
0.67Buy
0.69Buy
MA50
0.70Sell
0.72Sell
MA100
0.86Sell
0.82Sell
MA200
1.03Sell
0.91Sell
Cue Biopharma Inc’s (CUE) 10-Day exponential moving average is 0.70, while Cue Biopharma Inc’s (CUE) share price is $0.7, making it a Buy.
Cue Biopharma Inc’s (CUE) 100-Day exponential moving average is 0.82, while Cue Biopharma Inc’s (CUE) share price is $0.7, making it a Sell.
Cue Biopharma Inc’s (CUE) stock price is $0.7 and Cue Biopharma Inc’s (CUE) 50-day simple moving average is 0.70, creating a Sell signal.
Cue Biopharma Inc’s (CUE) stock price is $0.7 and Cue Biopharma Inc’s (CUE) 100-day simple moving average is 0.86, creating a Sell signal.
Cue Biopharma Inc’s (CUE) stock price is $0.7 and Cue Biopharma Inc’s (CUE) 200-day simple moving average is 1.03, creating a Sell signal.

Cue Biopharma (CUE) Technical Indicators

Jul 07, 2025, 06:36 PM
Name
Value
Implied Action
RSI (14)
51.63
Neutral
STOCH (9,6)
30.15
Neutral
STOCHRSI (14)
43.78
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
28.78
Neutral
Williams %R
-52.24
Buy
CCI (14)
35.64
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
46.49
Neutral
ROC
9.38
Buy
Cue Biopharma Inc’s (CUE) Relative Strength Index (RSI) is 51.63, creating a Neutral signal.
Cue Biopharma Inc’s (CUE) Trend Strength Indicator (ADX) is 28.78, creating a Neutral signal.
Cue Biopharma Inc’s (CUE) Commodity Channel Index (CCI) is 35.64, creating a Neutral signal.
Cue Biopharma Inc’s (CUE) Price Rate of Change (ROC) is 9.38, creating a Buy signal.

FAQ

Is CUE a Buy, Hold, or Sell?
Based on CUE’s technical indicators, CUE is a Hold.
    What is CUE’s RSI (14)?
    CUE’s RSI (14) is 51.63, which suggests CUE is a Neutral.
      What is CUE’s MACD?
      CUE’s MACD is <0.01, which suggests CUE is a Sell.
        What is CUE’s 5-day moving average?
        CUE’s 5-day moving average is 0.70, which suggests CUE is a Buy.
          What is CUE’s 20-day moving average?
          CUE 20-day moving average is 0.67, which suggests CUE is a Buy.
            What is CUE’s 50-day moving average?
            CUE’s 50-day moving average is 0.70, which suggests CUE is a Sell.
              What is CUE’s 200-day moving average?
              CUE’s 200-day moving average is 1.03, which suggests CUE is a Sell.
                What is CUE’s Williams % R (14)?
                CUE’s Williams % R (14) is -52.24, which suggests CUE is a Buy.
                  What is CUE’s CCI (14)?
                  CUE’s CCI (14) is 35.64, which suggests CUE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis